News: ZS Pharma Submits NDA for ZS-9 $ZSPH

ZS Pharma, Inc., a bio-pharmaceutical company, has submitted the New Drug Application (NDA) at FDA for its new medicine ZS-9.

The drug would be used for the treatment of hyperkalemia.

View the full release here.